Study design
This study consisted of a single centre, randomized, placebo-controlled, single-blind, clinical trial of methylene blue-based PDT in SARS-CoV-2 positive individuals. We aimed to evaluate safety, efficacy, and antiviral immune responses.Every participant was informed about the rationale and the characteristics of the study protocol and gave informed consent. The study, designed to follow CONSORT Statement criteria (